Sec Staff Action/letter (sec Staff)

Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)

Form 1-A Issuer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-A...

Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C.  20549   FORM 15   CERTIFI...

Annual Report (10-k)

  Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Quarterly Report (10-q)

  Table of Contents   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Quarterly Report (10-q)

  Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Quarterly Report (10-q)

  Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________   FORM...

Current Report Filing (8-k)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________   FORM...

Annual Report (10-k)

  Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Current Report Filing (8-k)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________   FORM...

DRWN - Potential Acquisition Candidate HIPAA Compliant Blockchain Collaboration with Oracle Corporation

DRWN – Potential Acquisition Candidate HIPAA Compliant Blockchain Collaboration with Oracle Corporation   Miami, FL -- April 3, 2018...

Statement of Ownership (sc 13g)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G Under the...

Analyst Pre-Market Updates: Intellicell Biosciences, Therapy Cells, Viper Networks, and Mentor Capitol

Intellicell Biosciences, Inc. (OTCQB: SVFC) is a pioneering regenerative medicine company focused on the expanding regenerative medical markets...

Press Release-08-20-2013